🔗 Visit the ClinicalTrials.gov page for NCT01248455
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. | Blood | 2009 | 5.69 |
| 2 | Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. | J Clin Oncol | 2007 | 3.32 |
| 3 | Clinically relevant end points and new drug approvals for myeloma. | Leukemia | 2007 | 2.91 |
| 4 | Immune checkpoint inhibitors in clinical trials. | Chin J Cancer | 2014 | 0.98 |
| 5 | A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma. | Haematologica | 2014 | 0.89 |
| 6 | Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions. | Clin Dev Immunol | 2012 | 0.88 |
| 7 | Immunotherapeutic approaches to treat multiple myeloma. | Hum Vaccin Immunother | 2013 | 0.77 |